Genelux Common Stock Buy Hold or Sell Recommendation
| GNLX Stock | 3.40 0.18 5.03% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Genelux Common is 'Cautious Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Genelux Common given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Genelux Common, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Genelux Common Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Genelux Stock please use our How to Invest in Genelux Common guide. In addition, we conduct extensive research on individual companies such as Genelux and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Genelux Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Genelux |
Execute Genelux Common Buy or Sell Advice
The Genelux recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Genelux Common. Macroaxis does not own or have any residual interests in Genelux Common or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Genelux Common's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | OK | Details | |
Volatility | Relatively risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Genelux Common Trading Alerts and Improvement Suggestions
| Genelux Common is way too risky over 90 days horizon | |
| Genelux Common appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 170 K. Net Loss for the year was (28.3 M) with profit before overhead, payroll, taxes, and interest of 8 K. | |
| Genelux Common generates negative cash flow from operations | |
| Genelux Common has a poor financial position based on the latest SEC disclosures | |
| About 17.0% of the company shares are held by company insiders |
Genelux Common Returns Distribution Density
The distribution of Genelux Common's historical returns is an attempt to chart the uncertainty of Genelux Common's future price movements. The chart of the probability distribution of Genelux Common daily returns describes the distribution of returns around its average expected value. We use Genelux Common price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Genelux Common returns is essential to provide solid investment advice for Genelux Common.
| Mean Return | 0.56 | Value At Risk | -10 | Potential Upside | 12.60 | Standard Deviation | 6.80 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Genelux Common historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Genelux Common Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 10.9M | (6.9M) | (4.1M) | 9.0M | 10.4M | 10.9M | |
| Free Cash Flow | (7.2M) | (6.6M) | (3.6M) | (21.3M) | (19.2M) | (18.2M) | |
| Depreciation | 658K | 895K | 968K | 1.0M | 1.2M | 883.5K | |
| Other Non Cash Items | 74K | 196K | (56K) | 5.1M | 5.8M | 6.1M | |
| Net Income | (13.6M) | (16.4M) | (5.2M) | (28.3M) | (25.5M) | (24.2M) | |
| End Period Cash Flow | 11.4M | 4.5M | 397K | 9.4M | 10.8M | 5.7M |
Genelux Common Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Genelux Common or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Genelux Common's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Genelux stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.75 | |
β | Beta against Dow Jones | 1.81 | |
σ | Overall volatility | 6.95 | |
Ir | Information ratio | 0.1 |
Genelux Common Volatility Alert
Genelux Common is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Genelux Common's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Genelux Common's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Genelux Common Fundamentals Vs Peers
Comparing Genelux Common's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Genelux Common's direct or indirect competition across all of the common fundamentals between Genelux Common and the related equities. This way, we can detect undervalued stocks with similar characteristics as Genelux Common or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Genelux Common's fundamental indicators could also be used in its relative valuation, which is a method of valuing Genelux Common by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Genelux Common to competition |
| Fundamentals | Genelux Common | Peer Average |
| Return On Equity | -0.97 | -0.31 |
| Return On Asset | -0.49 | -0.14 |
| Current Valuation | 91.63 M | 16.62 B |
| Shares Outstanding | 34.54 M | 571.82 M |
| Shares Owned By Insiders | 16.58 % | 10.09 % |
| Shares Owned By Institutions | 14.12 % | 39.21 % |
| Number Of Shares Shorted | 2.3 M | 4.71 M |
| Price To Book | 3.74 X | 9.51 X |
| Price To Sales | 14,679 X | 11.42 X |
| Revenue | 170 K | 9.43 B |
| Gross Profit | 8 K | 27.38 B |
| EBITDA | (26.46 M) | 3.9 B |
| Net Income | (28.3 M) | 570.98 M |
| Total Debt | 2.52 M | 5.32 B |
| Book Value Per Share | 0.97 X | 1.93 K |
| Cash Flow From Operations | (20.27 M) | 971.22 M |
| Short Ratio | 9.77 X | 4.00 X |
| Earnings Per Share | (0.94) X | 3.12 X |
| Target Price | 18.4 | |
| Number Of Employees | 25 | 18.84 K |
| Beta | -1.46 | -0.15 |
| Market Capitalization | 117.43 M | 19.03 B |
| Total Asset | 27.89 M | 29.47 B |
| Retained Earnings | (221.52 M) | 9.33 B |
| Working Capital | 17.65 M | 1.48 B |
| Net Asset | 27.89 M |
Note: Acquisition by Matthew Pulisic of 275000 shares of Genelux Common at 3.95 subject to Rule 16b-3 [view details]
Genelux Common Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Genelux . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Genelux Common Buy or Sell Advice
When is the right time to buy or sell Genelux Common? Buying financial instruments such as Genelux Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Genelux Common in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Money Market Funds Thematic Idea Now
Money Market Funds
Funds or Etfs investing in various types of short-term (less than one year) fixed income instruments of high-quality and liquidity. The Money Market Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Money Market Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Genelux Stock Analysis
When running Genelux Common's price analysis, check to measure Genelux Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genelux Common is operating at the current time. Most of Genelux Common's value examination focuses on studying past and present price action to predict the probability of Genelux Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genelux Common's price. Additionally, you may evaluate how the addition of Genelux Common to your portfolios can decrease your overall portfolio volatility.